Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over
Closed for comments This consultation ended on at Request commenting lead permission
4 Evaluation committee members and NICE project team
Evaluation committee members
The highly specialised technologies evaluation committee is a standing advisory committee of NICE.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered that there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
NICE project team
Each highly specialised technology evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser and a project manager.
Nigel Gumbleton
Technical lead
Joanna Richardson
Technical adviser
Daniel Davies
Project manager
ISBN: [to be added at publication]
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions